Doctors' Preferences for Their Own End-of-Life Care? No Life-Sustaining Practices
By Elana Gotkine HealthDay Reporter
FRIDAY, June 13, 2025 -- Many physicians would personally prefer to avoid life-sustaining practices if they had advanced cancer or Alzheimer disease, according to a study published online June 10 in the Journal of Medical Ethics.
Sarah Mroz, M.P.H., from the End-of-Life Care Research Group in Brussels, and colleagues conducted a cross-sectional survey in eight jurisdictions to examine physicians' personal preferences for end-of-life practices. A total of 1,157 survey responses from general practitioners, palliative care physicians, and other medical specialists were analyzed.
The researchers found that in advanced cancer and Alzheimer disease, respectively, physicians rarely considered life-sustaining practices a good or very good option (cardiopulmonary resuscitation, 0.5 and 0.2 percent; mechanical ventilation, 0.8 and 0.3 percent; tube feeding, 3.5 and 3.8 percent); euthanasia was considered a good or very good option by about half of physicians (54.2 percent for cancer and 51.5 percent for Alzheimer disease). The proportion of physicians considering euthanasia a good or very good option varied from 37.9 to 80.8 percent in Italy and Belgium, respectively, in the cancer scenario, and from 37.4 to 67.4 percent in Georgia, USA, and Belgium, respectively, in the Alzheimer disease scenario. The likelihood of considering euthanasia a good or very good option for both cancer and Alzheimer disease was higher for physicians practicing in a jurisdiction with a legal option for both euthanasia and physician-assisted suicide (odds ratios, 3.1 for cancer and 1.9 for Alzheimer disease).
"It is striking that many physicians would also consider euthanasia in the Alzheimer's disease scenario, despite the progressive status of this disease making it a complex basis for a competent assisted dying request. In most jurisdictions, the law would not allow physicians to grant this request," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-06-14 06:00
Read more

- Pheast Therapeutics Receives FDA Fast Track Designation for PHST001 for the Treatment of Ovarian Cancer
- GLP-1 Drugs Appear To Lower Cancer Risk
- Long-Lasting HIV Prevention Shot Headed Toward Approval
- Pediatric Skin Care Regimens on TikTok Offer Few Benefits, Possible Harm
- Prevalence of Disability Up Over Twofold for Current Smokers
- Work Context Linked to Cardiovascular Disease Risk Factors
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions